학술논문
Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020-February 2021.
Document Type
Academic Journal
Author
Dunajcik A; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Haire K; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Thomas JD; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Moriarty LF; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Springer Y; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Villanueva JM; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; MacNeil A; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Silk B; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Nemhauser JB; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Byrkit R; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Taylor M; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Queen K; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Tong S; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Lee J; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Batra D; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Paden C; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Henderson T; Michigan Department of Health and Human Services, Lansing, Michigan, United States of America.; Kunkes A; Georgia Department of Health, Atlanta, Georgia, United States of America.; Ojo M; New Jersey Department of Health, Trenton, New Jersey, United States of America.; Firestone M; Minnesota Department of Health, St. Paul, Minnesota, United States of America.; Epidemic Intelligence Service, CDC, Atlanta, Georgia, United States of America.; Martin Webb L; Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.; Freeland M; Texas Department of State Health Services, Austin, Texas, United States of America.; Brown CM; Massachusetts Department of Public Health, Boston, Massachusetts, United States of America.; Williams T; Maryland Department of Health, Baltimore, Maryland, United States of America.; CDC Foundation, Atlanta, Georgia, United States of America.; Allen K; Washington State Department of Health, Shoreline, Washington, United States of America.; Kauerauf J; Illinois Department of Public Health, Springfield, Illinois, United States of America.; Wilson E; North Carolina Department of Health and Human Services, Raleigh, North Carolina, United States of America.; Jain S; California Department of Public Health, Richmond, California, United States of America.; McDonald E; San Diego County Health and Human Services Agency, San Diego, California, United States of America.; Silver E; California Department of Public Health, Richmond, California, United States of America.; Stous S; San Diego County Health and Human Services Agency, San Diego, California, United States of America.; Wadford D; California Department of Public Health, Richmond, California, United States of America.; Radcliffe R; South Carolina Department of Health and Environmental Control, Columbia, South Carolina, United States of America.; Marriott C; Pennsylvania Department of Health, Pittsburgh, Pennsylvania, United States of America.; Owes JP; Alabama Department of Public Health, Montgomery, Alabama, United States of America.; Bart SM; Epidemic Intelligence Service, CDC, Atlanta, Georgia, United States of America.; Connecticut Department of Public Health, Hartford, Connecticut, United States of America.; Sosa LE; Connecticut Department of Public Health, Hartford, Connecticut, United States of America.; Oakeson K; Utah Department of Health, Salt Lake City, Utah, United States of America.; Wodniak N; Virginia Department of Health, Richmond, Virginia, United States of America.; Shaffner J; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Tennessee Department of Health, Nashville, Tennessee, United States of America.; Brown Q; Ohio Department of Health, Columbus, Ohio, United States of America.; Westergaard R; Wisconsin Department of Health Services, Madison, Wisconsin, United States of America.; Salinas A; Louisiana Department of Health, New Orleans, Louisiana, United States of America.; Hallyburton S; Indiana Department of Health, Indianapolis, Indiana, United States of America.; Ogale Y; Delaware Division of Public Health, Dover, Delaware, United States of America.; Offutt-Powell T; Delaware Division of Public Health, Dover, Delaware, United States of America.; Bonner K; Epidemic Intelligence Service, CDC, Atlanta, Georgia, United States of America.; Oregon Health Authority, Portland, Oregon, United States of America.; Tubach S; Kansas Department of Health and Environment, Topeka, Kansas, United States of America.; Van Houten C; Wyoming Department of Health, Cheyenne, Wyoming, United States of America.; Hughes V; Southern Nevada Health District, Las Vegas, Nevada, United States of America.; Reeb V; Iowa Department of Public Health, Des Moines, Iowa, United States of America.; Galeazzi C; Iowa Department of Public Health, Des Moines, Iowa, United States of America.; Khuntia S; District of Columbia Department of Health (DC Health), Washington, DC, United States of America.; McGee S; District of Columbia Department of Health (DC Health), Washington, DC, United States of America.; Hicks JT; Epidemic Intelligence Service, CDC, Atlanta, Georgia, United States of America.; New Mexico Department of Health, Santa Fe, New Mexico, United States of America.; Dinesh Patel D; Kentucky Department for Public Health, Frankfort, Kentucky, United States of America.; Krueger A; Maine Center for Disease Control and Prevention, Augusta, Maine, United States of America.; Hughes S; New York City Department of Health and Mental Hygiene, New York City, New York, United States of America.; Jeanty F; New York City Department of Health and Mental Hygiene, New York City, New York, United States of America.; Wang JC; New York City Department of Health and Mental Hygiene, New York City, New York, United States of America.; Lee EH; New York City Department of Health and Mental Hygiene, New York City, New York, United States of America.; Assanah-Deane T; New York City Department of Health and Mental Hygiene, New York City, New York, United States of America.; Tompkins M; Alaska Department of Health and Social Services, Anchorage, Alaska, United States of America.; Dougherty K; Oklahoma State Department of Health, Oklahoma City, Oklahoma, United States of America.; Naqvi O; Oklahoma State Department of Health, Oklahoma City, Oklahoma, United States of America.; Donahue M; Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America.; Frederick J; Douglas County Health Department, Omaha, Nebraska, United States of America.; Abdalhamid B; Nebraska Public Health Lab, Lincoln, Nebraska, United States of America.; Powers AM; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.; Anderson M; Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America.
Source
Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel history, demographics, and health outcomes for a convenience sample of persons infected with a SARS-CoV-2 VOC from December 15, 2020 through February 28, 2021 were provided by 35 state and city health departments, and proportion reporting travel was calculated. Of 1,761 confirmed VOC cases analyzed, 1,368 had available data on travel history. Of those with data on travel history, 1,168 (85%) reported no travel preceding laboratory confirmation of SARS-CoV-2 and only 105 (8%) reported international travel during the 30 days preceding a positive SARS-CoV-2 test or symptom onset. International travel was reported by 92/1,304 (7%) of persons infected with the Alpha variant, 7/55 (22%) with Beta, and 5/9 (56%) with Gamma. Of the first three SARS-CoV-2 lineages designated as VOCs in the U.S., international travel was common only among the few Gamma cases. Most persons infected with Alpha and Beta variant reported no travel history, therefore, community transmission of these VOCs was likely common in the U.S. by March 2021. These findings underscore the importance of global surveillance using whole genome sequencing to detect and inform mitigation strategies for emerging SARS-CoV-2 VOCs.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)